期刊文献+

未接受HAART的HIV/AIDS患者血清隐球菌抗原阳性率调查 被引量:5

Investigation of serum cryptococcal antigen positive rates in HIV/AIDS patients without receiving HAART
下载PDF
导出
摘要 目的调查未接受高效抗反转录病毒治疗(highly active antiretroviral therapy,HAART)的HIV/AIDS患者血清隐球菌抗原的阳性率。方法回顾性调查我院感染科2012年1—9月住院的77例未接受HAART的HIV/AIDS患者外周血CD4+T淋巴细胞计数及血清隐球菌抗原阳性率,比较隐球菌抗原阳性患者与阴性患者的CD4+T淋巴细胞计数。结果 77例(男53例,女24例)中,血清隐球菌抗原阳性48例,阳性率为62.34%,阴性29例,阴性率为37.66%。其中,CD4+T淋巴细胞计数≤50个/mm3的患者血清隐球菌抗原阳性率为72.73%。血清隐球菌抗原阳性患者外周血CD4+T淋巴细胞计数显著低于阴性患者(P=0.022)。结论未接受HAART的外周血CD4+T淋巴细胞计数较低的HIV/AIDS患者血清隐球菌抗原阳性率高,血清隐球菌抗原阳性患者CD4+T淋巴细胞水平低于阴性患者(P<0.05)。 Objective To investigate the positive rates of serum cryptococcal antigen in HIV/AIDS patients without initiating highly active antiretroviral therapy (HAART). Methods CD4+ T lymphocyte counts and the positive rates of serum cryptococcal antigen of 77 HIV/AIDS patients without initiating HAART, who were hospitalized in the department of infectious diseases of our hospital from Jan. to Sept. 2012, were analyzed retrospectively. CD4+ T lymphocyte counts were compared between serum cryptococ- cal antigen positive patients and negative patients. Results Of 77 HIV/AIDS patients (53 males and 24 females), 48 (62.34%) were serum cryptococcal antigen positive, and 29 (37.66%) were serum cryptococcal antigen negative. The positive rate of serum crypto- coccal antigen was 72.73% in the patients with CD4+ T lymphocyte count ≤ 50/mm3. CD4+ T lymphocyte counts of the cryptococcal antigen positive patients were significantly lower than those of the negative patients (P=0.022). Conclusions This study reveals a high prevalence of cryptococcal antigen in HIV/AIDS patients without receiving HAART whose CD4+ T lymphocyte counts are lower. CD4+ T lymphocyte counts of HIV/AIDS patients with serum eryptococcal antigen positive are significantly lower than those of HIV/ AIDS patients with serum cryptococcal antigen negative (P〈0.05).
出处 《传染病信息》 2012年第6期353-355,384,共4页 Infectious Disease Information
基金 国家"十二五"科技重大专项(2012ZX10001-003-001) 2009郑州市科技攻关项目(N2008SP0138)
关键词 获得性免疫缺陷综合征 HIV 新型隐球菌 T-淋巴细胞 acquired immunodeficiency syndrome HIV Cryptococcus neoformans T-lymphocytes
  • 相关文献

参考文献17

  • 1Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J]. AIDS, 2009, 23(4):525-530.
  • 2卢洪洲,曹天高,周颖杰,尹有宽,潘孝彰,翁心华.乳胶凝集试验对新型隐球菌性脑膜炎诊断及治疗的意义[J].中华传染病杂志,2005,23(3):209-211. 被引量:45
  • 3Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of com- mercial kits for detection of cryptococcal antigen[J ]. J Clin Micro- biol, 1994, 32(7):1680-1684.
  • 4中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南(2011版)[J].中华临床感染病杂志,2011,4(6). 被引量:379
  • 5汪习成,樊移山.AIDS并发隐球菌脑膜炎的诊断和治疗[J].传染病信息,2009,22(6):370-374. 被引量:13
  • 6Waters L, Nelson M. Cryptococcal disease and HIV infection[J]. Expert Opin Pharmacother, 2005, 15(15):2633-2644.
  • 7Crump JA, Ramadhani HO, Morrissey AB, et ol. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV- uninfected adults and adolescents in northern Tanzania[J]. Clin Infect Dis, 2011, 52(3):341-348.
  • 8宋蕊,陈志海.AIDS肺部真菌感染诊治研究进展[J].传染病信息,2011,24(6):377-380. 被引量:4
  • 9Osazuwa F, Dirisu JO, Okuonghae PE, et al. Screening for crypto- coccal antigenemia in anti-retroviral na'l"ce AIDS patients in benin city, Nigeria[J]. Oman Med J, 2012, 27(3):228-231.
  • 10Pongsai P, Atamasirikul K, Sungkanuparph S. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococ- cosis in HIV-infected patients with different ranges of CD4 cell counts[J]. J Infect, 2010, 60(6):474-477.

二级参考文献117

共引文献454

同被引文献62

  • 1康来仪.应重视艾滋病中枢神经系统感染性疾病的防治与研究[J].中国现代神经疾病杂志,2004,4(4):197-199. 被引量:9
  • 2卢洪洲,曹天高,周颖杰,尹有宽,潘孝彰,翁心华.乳胶凝集试验对新型隐球菌性脑膜炎诊断及治疗的意义[J].中华传染病杂志,2005,23(3):209-211. 被引量:45
  • 3徐金锁,张宪敏,雷庆.两性霉素B联合氟康唑治疗真菌性角膜溃疡26例疗效观察[J].黑龙江医学,2007,31(1):39-40. 被引量:4
  • 4何俊瑛,何红彦,孟兆华,金便芬.隐球菌性脑膜炎早期诊断及疗效探讨(附30例报道)[J].中国神经精神疾病杂志,2007,33(7):433-435. 被引量:24
  • 5Denning DW, Kibhler CC, Barnes RA, etal. British society for medical mycology proposed standards of care for patients with in vasive fungal infections[J]. Lancet Infect Dis, 2003, 3 (4) : 230- 240.
  • 6Rees JR,Pinner RW, ttaiieh RA,et al. The epidemielogical fea- tures of invasive mycotic infections in the San Francisco Bay Are-a, 1992-1993 :resuhs of population-based laboratory active surveil- lance[J]. Clin Infect Dis, 1998,27(5) :1138-1147.
  • 7Denning DW, Hope WW. Therapy for fungal diseases:opportuni- ties and priorities[J]. Trends Microbiol,2010,18(5) :195 204.
  • 8Crump J A, Ramadhani HO, Morrissey AB, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV- uninfected children and infants in northern Tanzania [J]. Trop Med Int Health, 2011,16(7) :830-837.
  • 9Huang L, Crotbers K. HIV-associated opportunistic pneumonias [J]. Respirology, 2009,14(4) :474-485.
  • 10Shen YZ, Qi TK, Ma JX, et al. Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital[J]. Mycoses,2007,50(6) :475-480.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部